154 related articles for article (PubMed ID: 29526504)
1. Efficient hydroxylation of cycloalkanes by co-addition of decoy molecules to variants of the cytochrome P450 CYP102A1.
Dezvarei S; Onoda H; Shoji O; Watanabe Y; Bell SG
J Inorg Biochem; 2018 Jun; 183():137-145. PubMed ID: 29526504
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1.
Dezvarei S; Lee JHZ; Bell SG
Enzyme Microb Technol; 2018 Apr; 111():29-37. PubMed ID: 29421034
[TBL] [Abstract][Full Text] [Related]
3. Hoodwinking Cytochrome P450BM3 into Hydroxylating Non-Native Substrates by Exploiting Its Substrate Misrecognition.
Shoji O; Aiba Y; Watanabe Y
Acc Chem Res; 2019 Apr; 52(4):925-934. PubMed ID: 30888147
[TBL] [Abstract][Full Text] [Related]
4. Selective hydroxylation of 1,8- and 1,4-cineole using bacterial P450 variants.
Lee JHZ; Wong SH; Stok JE; Bagster SA; Beckett J; Clegg JK; Brock AJ; De Voss JJ; Bell SG
Arch Biochem Biophys; 2019 Mar; 663():54-63. PubMed ID: 30590022
[TBL] [Abstract][Full Text] [Related]
5. Chimeragenesis of the fatty acid binding site of cytochrome P450BM3. Replacement of residues 73-84 with the homologous residues from the insect cytochrome P450 CYP4C7.
Murataliev MB; Trinh LN; Moser LV; Bates RB; Feyereisen R; Walker FA
Biochemistry; 2004 Feb; 43(7):1771-80. PubMed ID: 14967018
[TBL] [Abstract][Full Text] [Related]
6. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
Budde M; Morr M; Schmid RD; Urlacher VB
Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
8. Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants.
Feenstra KA; Starikov EB; Urlacher VB; Commandeur JN; Vermeulen NP
Protein Sci; 2007 Mar; 16(3):420-31. PubMed ID: 17322527
[TBL] [Abstract][Full Text] [Related]
9. Roles of key active-site residues in flavocytochrome P450 BM3.
Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
[TBL] [Abstract][Full Text] [Related]
10. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
11. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants.
Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH
Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345
[TBL] [Abstract][Full Text] [Related]
12. Direct Hydroxylation of Benzene to Phenol by Cytochrome P450BM3 Triggered by Amino Acid Derivatives.
Shoji O; Yanagisawa S; Stanfield JK; Suzuki K; Cong Z; Sugimoto H; Shiro Y; Watanabe Y
Angew Chem Int Ed Engl; 2017 Aug; 56(35):10324-10329. PubMed ID: 28544674
[TBL] [Abstract][Full Text] [Related]
13. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
14. Computational redesign of cytochrome P450 CYP102A1 for highly stereoselective omeprazole hydroxylation by UniDesign.
Huang X; Sun Y; Osawa Y; Chen YE; Zhang H
J Biol Chem; 2023 Aug; 299(8):105050. PubMed ID: 37451479
[TBL] [Abstract][Full Text] [Related]
15. The Stereoselective Oxidation of para-Substituted Benzenes by a Cytochrome P450 Biocatalyst.
Chao RR; Lau IC; Coleman T; Churchman LR; Child SA; Lee JHZ; Bruning JB; De Voss JJ; Bell SG
Chemistry; 2021 Oct; 27(59):14765-14777. PubMed ID: 34350662
[TBL] [Abstract][Full Text] [Related]
16. Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450
Geronimo I; Denning CA; Heidary DK; Glazer EC; Payne CM
Biophys J; 2018 Oct; 115(7):1251-1263. PubMed ID: 30224054
[TBL] [Abstract][Full Text] [Related]
17. Novel cyclohexane monooxygenase from Acidovorax sp. CHX100.
Salamanca D; Karande R; Schmid A; Dobslaw D
Appl Microbiol Biotechnol; 2015 Aug; 99(16):6889-97. PubMed ID: 25935342
[TBL] [Abstract][Full Text] [Related]
18. A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes.
Appel D; Lutz-Wahl S; Fischer P; Schwaneberg U; Schmid RD
J Biotechnol; 2001 Jun; 88(2):167-71. PubMed ID: 11403851
[TBL] [Abstract][Full Text] [Related]
19. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
20. Tuning the regio- and stereoselectivity of C-H activation in n-octanes by cytochrome P450 BM-3 with fluorine substituents: evidence for interactions between a C-F bond and aromatic π systems.
Wu LL; Yang CL; Lo FC; Chiang CH; Chang CW; Ng KY; Chou HH; Hung HY; Chan SI; Yu SS
Chemistry; 2011 Apr; 17(17):4774-87. PubMed ID: 21400620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
